Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Editorial

A patchwork policy: vaccination in Canada

CMAJ March 04, 2003 168 (5) 533;
  • Article
  • Responses
  • Metrics
  • PDF
Loading

In 1796, when Edward Jenner induced immunity to smallpox in 8-year-old James Phipps, he recognized in his discovery “the hope of it becoming essentially beneficial to mankind.”1 Although his experiment would fail ethical scrutiny today, it was one of the most productive moments of the Enlightenment. Further enlightenment on this front has been both glorious and fitful. The second vaccine, for rabies, was not developed until 1885, followed by one for the plague in 1897 and then — all before World War II — vaccines against diphtheria, pertussis, tetanus and yellow fever. Recently, the pace of development has accelerated, adding vaccines against Haemophilus influenzae type b, hepatitis A and B, influenza, pneumococcal and meningococcal infection and varicella to well-established vaccines for polio, measles, mumps and rubella. (The pace of vaccine development and delivery in the developing world is, of course, another matter.)

With scientific gains come new complexities. Earlier vaccines combated common diseases that often had severe consequences. More recent vaccines prevent less common infections, such as pneumococcus and meningococcus, that nonetheless can be fatal or severe, or common ones, such as chickenpox, that only rarely have grave effects.2

A further complexity is that the near-complete immunization of whole populations in childhood has led, decades later, to whole populations of adults with waning immunity to some childhood diseases.3,4 Pertussis, for example, is now as common among adults as among children, creating important questions about the need to revaccinate adolescents and adults.

Although expert groups such as the National Advisory Committee on Immunization make national recommendations, implementation is up to the provinces. Faced with the variable cost-effectiveness of a growing number of new vaccines, the provinces have hesitated to expand immunization programs. The result is a patchwork of policies (see News, page 598). In Newfoundland and Labrador, for example, children do not routinely receive pneumococcal vaccination; in Alberta, they do. In Quebec, all children are vaccinated against meningococcus; in Ontario, they are not.

A young girl in Ottawa died recently from meningococcal meningitis; it is sad to consider how things might have been had she lived a mile away, in Gatineau, where meningococcal vaccination is routine. Those of us who live near the US border might also ponder why 75% of American children are now vaccinated against chickenpox, while few Canadian children are. Even more alarmingly, there is such a lack of national leadership that Canada does not even track varicella vaccine use or rates of varicella disease. Regional deficiencies will only become more complex as new vaccines come on the market. When a vaccine for human papillomavirus becomes available,5 will girls in Newfoundland and Ontario be denied this protection?

As memory fades of the scourges of the past, and as more vaccines are recommended, the anti-immunization lobby will become more worrisome.6,7 Unless a large proportion (usually over 95%) of the population is vaccinated, herd immunity will not result and outbreaks will recur. A rational policy can only be comprehensive and consistent. Even setting aside the advantages of herd immunity, Canada's current policy of recommending vaccines but not supporting their delivery in national programs makes little sense. The costs of purchasing and administering a single dose of vaccine can be prohibitive for an individual. For example, pneumococcus vaccine for a child in Ontario costs $370. If this vaccine were made a staple of childhood immunization, its cost would plummet and the cost–benefit ratio would become more favourable.

Roy Romanow has recommended a national vaccination strategy in Canada.8 This must be more than an advisory committee. Although such an expert group is indispensible, we also need national leadership, national promotion, and national funding. We support Monika Naus and David Scheifele's open letter to Health Minister Anne McLellan in this issue (see page 567), and urge the creation of a National Office for Immunization. — CMAJ

References

  1. 1.↵
    Jenner E. An inquiry into the causes and effects of the variolae vaccinae, or cow-pox. London: 1798.
  2. 2.↵
    Law BJ. Chickenpox vaccination, not chickenpox, should be routine for Canadian children [editorial]. CMAJ 2001;164(10):1454-5.
    OpenUrlFREE Full Text
  3. 3.↵
    Hoey J. Varicella vaccine update: Need for a booster? CMAJ 2003; 168 (5): 589.
    OpenUrlFREE Full Text
  4. 4.↵
    Shapiro H, Weir E. Measles in your office [published erratum appears in CMAJ 2002;166(8):1015]. CMAJ 2001;164(11):1614.
    OpenUrlFREE Full Text
  5. 5.↵
    Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347(21):1645-51.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Pless R, Hibbs B. Chiropractic students' attitudes about vaccination: A cause for concern? [editorial]. CMAJ 2002;166(12):1544-5.
    OpenUrlFREE Full Text
  7. 7.↵
    Vaccination: refuting the refusals [editorial]. CMAJ 2000;163(7):801.
    OpenUrlFREE Full Text
  8. 8.↵
    Romanow RJ. Building on values: the future of health care in Canada. Saskatoon: Commission on the Future of Health Care in Canada; 2002. p. 134.
PreviousNext
Back to top

In this issue

CMAJ
Vol. 168, Issue 5
4 Mar 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A patchwork policy: vaccination in Canada
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A patchwork policy: vaccination in Canada
CMAJ Mar 2003, 168 (5) 533;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
A patchwork policy: vaccination in Canada
CMAJ Mar 2003, 168 (5) 533;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Environmental scan of provincial and territorial planning for COVID-19 vaccination programs
  • Vaccinating in the age of apathy: measles vaccination in Canada, 1963-1998
  • Informed consent for uninsured services: a primary care perspective on the new childhood vaccines
  • Canada's Public Health Agency: Bound and gagged?
  • Creating immunity
  • Creating immunity
  • Canada needs a national immunization program: an open letter to the Honourable Anne McLellan, federal minister of health
  • Google Scholar

More in this TOC Section

  • La vaccination contre le SRAS-CoV-2 devrait être obligatoire pour exercer la médecine au Canada
  • Reconstruire de façon plus équitable
  • Contrer les variants plus virulents du SRAS-CoV-2 demandera une réponse plus ingénieuse à la pandémie
Show more Éditorial

Similar Articles

Collections

  • Topics
    • Canadian government
    • Vaccination

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire